KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Capital Expenditures (2016 - 2025)

Cvs Health's Capital Expenditures history spans 17 years, with the latest figure at $784.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 2.08% year-over-year to $784.0 million, compared with a TTM value of $2.8 billion through Dec 2025, up 1.83%, and an annual FY2025 reading of $2.8 billion, up 1.83% over the prior year.
  • Capital Expenditures for Q4 2025 was $784.0 million at Cvs Health, up from $698.0 million in the prior quarter.
  • The five-year high for Capital Expenditures was $1.1 billion in Q1 2022, with the low at $408.0 million in Q2 2022.
  • Average Capital Expenditures over 5 years is $694.6 million, with a median of $679.0 million recorded in 2022.
  • Year-over-year, Capital Expenditures skyrocketed 44.85% in 2023 and then dropped 28.35% in 2024.
  • Tracing CVS's Capital Expenditures over 5 years: stood at $597.0 million in 2021, then rose by 15.24% to $688.0 million in 2022, then soared by 32.41% to $911.0 million in 2023, then dropped by 15.7% to $768.0 million in 2024, then rose by 2.08% to $784.0 million in 2025.
  • Per Business Quant, the three most recent readings for CVS's Capital Expenditures are $784.0 million (Q4 2025), $698.0 million (Q3 2025), and $607.0 million (Q2 2025).